KSC-20190429-PH_KLS01_0019
Dr. Edward Kelly, with the University of Washington School of Pharmacy, discusses The Tissue Chips in Space project during a What’s On Board science briefing to NASA Social participants at the agency’s Kennedy Space Center in Florida on April 29, 2019. The briefing was held for SpaceX’s 17th Commercial Resupply Services (CRS-17) mission to the International Space Station. Kelly and other researchers will send kidney tissue chip models to the space station to understand how microgravity affects kidney function, such as changes in vitamin D metabolism and formation of kidney stones. NASA’s Orbiting Carbon Observatory-3 (OCO-3) and Space Test Program-Houston 6 (STP-H6) are two of the experiments that also will be delivered to the space station on CRS-17. The SpaceX Falcon 9 rocket and Dragon cargo module are scheduled to launch no earlier than May 3, 2019, from Space Launch Complex 40 on Cape Canaveral Air Force Station in Florida. Photo credit: NASA/Kim Shiflett
KSC-20190429-PH_KLS01_0019
Dr. Edward Kelly, with the University of Washington School of Pharmacy, discusses The Tissue Chips in Space project during a What’s On Board science briefing to NASA Social participants at the agency’s Kennedy Space Center in Florida on April 29, 2019. The briefing was held for SpaceX’s 17th Commercial Resupply Services (CRS-17) mission to the International Space Station. Kelly and other researchers will send kidney tissue chip models to the space station to understand how microgravity affects kidney function, such as changes in vitamin D metabolism and formation of kidney stones. NASA’s Orbiting Carbon Observatory-3 (OCO-3) and Space Test Program-Houston 6 (STP-H6) are two of the experiments that also will be delivered to the space station on CRS-17. The SpaceX Falcon 9 rocket and Dragon cargo module are scheduled to launch no earlier than May 3, 2019, from Space Launch Complex 40 on Cape Canaveral Air Force Station in Florida. Photo credit: NASA/Kim Shiflett